ワクチン送達デバイス市場規模、シェア、成長分析：デバイスタイプ別、投与経路別、エンドユーザー別、地域別 - 産業予測 2025～2032年

ワクチン送達デバイス市場規模は2023年に67億7,000万米ドルと評価され、2024年の73億3,000万米ドルから2032年には138億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.3％で成長する見通しです。

世界のワクチン送達デバイス市場は、予防接種イニシアチブの増加と効率的な投与方法への需要に後押しされ、力強い成長を遂げています。主な促進要因としては、予防接種プログラムの拡大、注射針技術の進歩、予防ヘルスケアに対する意識の高まりなどが挙げられます。特に、適切な冷蔵設備がない地域では、信頼できるコールドチェーンの重要性が強調されています。自動無効化シリンジやプレフィルドシリンジシステムなど、送達装置における最近の技術革新は、安全性と有効性を高めています。現在、北米と欧州が市場をリードしているが、アジア太平洋地域は大きな成長の可能性を秘めています。ワクチン需要の急増に伴い、市場は革新的で使い勝手が良く、費用対効果の高い送達ソリューションに重点を置いて進化する態勢を整えています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析
• 技術分析

ワクチン送達デバイス市場規模：デバイスタイプ別& CAGR（2025-2032）

• 市場概要
• 無針注射システム
• 経口投与システム
• 鼻腔デリバリーシステム
• ジェットインジェクター
• マイクロニードルパッチ
• マイクロインジェクター

ワクチン送達デバイス市場規模：投与経路別& CAGR（2025-2032）

• 市場概要
• 皮内ワクチン接種
• 筋肉ワクチン接種
• 皮下ワクチン接種
• その他の予防接種

ワクチン送達デバイス市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• クリニック
• その他のエンドユーザー

ワクチン送達デバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Becton Dickinson & Company（USA）
• Bioject Medical Technologies, Inc.（USA）
• Inovio Pharmaceuticals, Inc.（USA）
• PharmaJet（USA）
• Vaxxas（Australia）
• Gerresheimer AG（Germany）
• SCHOTT AG（Germany）
• Corium International, Inc.（USA）
• 3M（USA）
• West Pharmaceutical Services, Inc.（USA）
• Terumo Corporation（Japan）
• B. Braun Melsungen AG（Germany）
• Smiths Medical（UK）
• Medtronic（Ireland）
• Sanofi Pasteur（France）
• Novartis AG（Switzerland）
• Pfizer Inc.（USA）
• GlaxoSmithKline plc（UK）
• Merck & Co., Inc.（USA）
• Johnson & Johnson（USA）

結論と提言

Vaccine Delivery Devices Market size was valued at USD 6.77 billion in 2023 and is poised to grow from USD 7.33 billion in 2024 to USD 13.88 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global vaccine delivery devices market is experiencing robust growth, fueled by increased vaccination initiatives and the demand for efficient administration methods. Key drivers include the expansion of immunization programs, advancements in needle technology, and heightened awareness of preventive healthcare. A crucial concern remains the integrity of vaccines during storage and transport, emphasizing the importance of a reliable cold chain, particularly in areas lacking proper refrigeration. Recent innovations in delivery devices, including auto-disable syringes and prefilled syringe systems, enhance safety and efficacy. While North America and Europe currently lead the market, the Asia-Pacific region shows significant growth potential. As vaccine demand surges, the market is poised for evolution with an emphasis on innovative, user-friendly, and cost-effective delivery solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vaccine Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vaccine Delivery Devices Market Segments Analysis

Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vaccine Delivery Devices Market

The increasing demand for vaccines, fueled by continuous initiatives aimed at tackling infectious diseases like COVID-19 and various preventable illnesses, has created a significant driver for the vaccine delivery devices market. As global health efforts intensify, the necessity for efficient and reliable delivery systems becomes paramount to guarantee proper immunization. This surge in vaccine production and distribution emphasizes the critical role that advanced delivery devices play in enhancing vaccination rates and ensuring the effectiveness of immunization programs. Consequently, the growth of the vaccine delivery devices market is closely linked to the rising urgency for innovative solutions that meet the needs of public health initiatives.

Restraints in the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market faces significant constraints due to the high costs associated with developing and manufacturing advanced technologies. The extensive research and development required can lead to substantial expenses, which are often transferred to end-users such as healthcare facilities and patients. This financial burden can hinder the widespread adoption of these innovative devices, especially in resource-limited environments. Consequently, the cost-related barriers may restrict access in certain regions, preventing the full realization of the benefits that these advanced vaccine delivery solutions can offer in enhancing immunization efforts and overall public health outcomes.

Market Trends of the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market is witnessing a notable trend towards innovations in needle-free delivery systems, which are rapidly gaining traction among healthcare providers and patients alike. These advanced technologies, including jet injectors, microneedle patches, and nasal sprays, address common concerns associated with traditional needle-based vaccinations, such as anxiety and needle-stick injuries. By offering alternative delivery methods, these innovations not only enhance patient compliance but also improve vaccine stability and efficacy. As vaccination campaigns become increasingly critical, the shift towards needle-free solutions is expected to drive market growth, enhance operational efficiencies, and transform the overall vaccination experience.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Vaccine Delivery Devices Market Size by Type of Device & CAGR (2025-2032)

• Market Overview
• Needle-Free Injection Systems
• Oral Delivery Systems
• Nasal Delivery Systems
• Jet Injectors
• Microneedle Patches
• Microinjectors

Global Vaccine Delivery Devices Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Global Vaccine Delivery Devices Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Other End Users

Global Vaccine Delivery Devices Market Size & CAGR (2025-2032)

• North America (Type of Device, Route of Administration, End Users)
  • US
  • Canada
• Europe (Type of Device, Route of Administration, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Device, Route of Administration, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Device, Route of Administration, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Device, Route of Administration, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton Dickinson & Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxas (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corium International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations